Bengaluru, India

Awadut Gajendra Giri

This inventor holds 17 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 7 EPO patents, primarily in Glycosidase Inhibitors. Top assignee: Asceneuron Sa. Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Awadut Gajendra Giri. Retrieved from https://idiyas.com/inventor/awadut-gajendra-giri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 17 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 3.5

ph-index = 8

Forward Citations = 119(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Piperazine Derivatives
Glycosidase Inhibitors
Acid Addition Salts
Sulfoximine Compounds
Tetrahydro-Benzoazepine
Spiro Compounds
Annulated Compounds
Linear Inhibitors
Substituted Dihydrobenzofuran
Enantiomer Separation
Medicinal Chemistry
17 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Awadut Gajendra Giri

Introduction

Awadut Gajendra Giri is a prominent inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on piperazine derivatives. With a total of 17 patents to his name, Giri has established himself as a key figure in the development of pharmaceutical ingredients.

Latest Patents

Giri's latest patents include the invention of acid addition salts of piperazine derivatives. This invention relates to the acid addition salts, as well as solid forms, such as polymorphic forms, which are useful as pharmaceutical ingredients and, in particular, as glycosidase inhibitors. Another notable patent involves succinate and fumarate acid addition salts of piperazine derivatives. This invention also focuses on the solid forms, including polymorphic forms, that serve as pharmaceutical ingredients and glycosidase inhibitors.

Career Highlights

Throughout his career, Giri has worked diligently to advance pharmaceutical science. His innovative approaches have led to the development of new compounds that have the potential to improve therapeutic outcomes. His work is characterized by a commitment to research and a passion for innovation.

Collaborations

Giri has collaborated with several talented individuals in his field, including Anna Quattropani and Santosh Shripad Kulkarni. These collaborations have further enhanced his research and contributed to the success of his inventions.

Conclusion

Awadut Gajendra Giri's contributions to the pharmaceutical industry through his patents on piperazine derivatives highlight his innovative spirit and dedication to improving healthcare. His work continues to inspire future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…